The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The endogenous cannabinoid system controls extinction of aversive memories
Abstract
Acquisition and storage of aversive memories is one of the basic principles of central nervous systems throughout the animal kingdom. In the absence of reinforcement, the resulting behavioural response will gradually diminish to be finally extinct. Despite the importance of extinction, its cellular mechanisms are largely unknown. The cannabinoid receptor 1 (CB1) and endocannabinoids are present in memory-related brain areas and modulate memory. Here we show that the endogenous cannabinoid system has a central function in extinction of aversive memories. CB1-deficient mice showed strongly impaired short-term and long-term extinction in auditory fear-conditioning tests, with unaffected memory acquisition and consolidation. Treatment of wild-type mice with the CB1 antagonist SR141716A mimicked the phenotype of CB1-deficient mice, revealing that CB1 is required at the moment of memory extinction. Consistently, tone presentation during extinction trials resulted in elevated levels of endocannabinoids in the basolateral amygdala complex, a region known to control extinction of aversive memories. In the basolateral amygdala, endocannabinoids and CB1 were crucially involved in long-term depression of GABA (gamma-aminobutyric acid)-mediated inhibitory currents. We propose that endocannabinoids facilitate extinction of aversive memories through their selective inhibitory effects on local inhibitory networks in the amygdala.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Following their binding to central nervous system receptors (e.g.CB1 receptors), endocannabinoids have been shown, e.g., to reduce anxiety (Marsicano et al., 2002;Lutz et al., 2015) and increase food intake (Di Marzo et al., 2001).”
From Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (2016) · cites this paper as Marsicano et al., 2002
In the citing paper
“Moreover, there is an emerging body of evidence demonstrating an important role for CB1 receptor-mediated endocannabinoid signaling in the extinction of aversive memories8.”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [8]
In the citing paper
“As part of this protective role under aversive conditions, elevated EC signaling during stress has been shown to dampen the development of anxiety [12] and to regulate the encoding [13], retrieval [14] and extinction [15] of traumatic memories.”
From Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder (2013) · cites this paper as [15]
In the citing paper
“Additionally, inhibition of FAAH facilitates long-term fear extinction and rescues deficient fear extinction in rodent models by enhancing AEA–CB1 (cannabinoid type 1) receptor signaling and synaptic plasticity in the BLA.”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“Marsicano and colleagues reported elevated AEA and 2-AG BLA levels after extinction training in mice [86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“One notable finding is that a CB1R-dependent form of synaptic plasticity in BLA [51,86], long-term depression of inhibitory GABAergic transmission (LTDi), is enhanced by FAAH KO [51] and by the FAAH inhibitor AM3506 at doses that promote extinction [50].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“and produced impairments in extinction learning (but not fear conditioning) by CB1R KO or systemic antagonist (SR141716A) administration [28,86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“This suggests a scheme in which AEA released during extinction relieves a tonic inhibitory brake on BLA output neurons [50,51,86] necessary for the encoding of extinction memories [102] (Figure 2).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“The cannabinoid system is part of the complex circuitry that regulates anxiety and stress and is a crucial mediator of emotional learning (Marsicano et al, 2002;Viveros et al, 2005;Patel et al, 2005Patel et al, , 2005a; Laviolette and Grace, 2006;Varvel et al, 2007;Ganon-Elazar and Akirav, 2009;Lutz, 2009;Hill et al, 2009;Abush and Akirav, 2010;Akirav, 2011).”
From Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (2012) · cites this paper as Marsicano et al, 2002
Citations
Cites
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Genetic enhancement of learning and memory in mice
Tang, Y., Shimizu, E., Dubé, G., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,878
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
The role of ventromedial prefrontal cortex in the recovery of extinguished fear
Quirk, G. J., Russo, G. K., Barron, J. L., & Lebron, K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06225.2000 · Cited by 957 · cited 1×
“; however, there is increasing evidence that some cellular pathways are specifically involved in extinction, but not in acquisition or consolidation of fear memorie”
BackgroundMarsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Self-citationExtinction of emotional learning: contribution of medial prefrontal cortex
Morgan, M. A., Romanski, L. M., & LeDoux, J. E. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90241-c · Cited by 897 · cited 1×
“To confirm this assumption, we measured in C57BL/6J mice levels of the two major endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), in brain punches of the medial prefrontal cortex (mPFC) and the basolateral amygdala complex (BLAC), both of which are thought to have central roles in extinction of av…”
BackgroundOhno‐Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 874
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Research works printed but not linked: 1
- Franklin, K. B. J. & Paxinos, G. The Mouse Brain (Academic, San Diego, 1997)
Cited by
Sorted by citations
Items 901–1,000 of 1,005
Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor
Deis, S., Srivastava, R. K., de Azúa, I. R., Bîndilă, L., Baraghithy, S., Lutz, B., Bab, I., & Tam, J. (2017) · Bone · doi:10.1016/j.bone.2017.12.018 · Cited by 32
Self-citationMalikowska‐Racia, N., Sałat, K., Nowaczyk, A., Fijałkowski, Ł., & Popik, P. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.012 · Cited by 30
Rovira-Esteban, L., Gunduz‐Cinar, O., Bukalo, O., Limoges, A., Brockway, E. T., Müller, K., Fenno, L. E., Kim, Y. S., Ramakrishnan, C., Andrási, T., et al. (2019) · eNeuro · doi:10.1523/eneuro.0220-19.2019 · Cited by 34
Inhibitory Plasticity: From Molecules to Computation and Beyond
Gandolfi, D., Bigiani, A., Porro, C. A., & Mapelli, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051805 · Cited by 36
Suplita, R. L., Eisenstein, S. A., Neely, M. H., Moise, A. M., & Hohmann, A. G. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.006 · Cited by 33
Ford, G. K., Kieran, S., Dolan, K., Harhen, B., & Finn, D. P. (2011) · Pain · doi:10.1016/j.pain.2011.07.014 · Cited by 32
Endocannabinoid signalling in Alzheimer's disease
Maroof, N., Pardon, M., & Kendall, D. A. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130140 · Cited by 34
Shoshan, N., & Akirav, I. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.08.004 · Cited by 33
Enhanced anandamide signaling reduces flight behavior elicited by an approaching robo-beetle
Heinz, D. E., Genewsky, A. J., & Wotjak, C. T. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.010 · Cited by 33
Self-citationSilva‐Peña, D., Rivera, P., Alén, F., Vargas, A., Rubio, L., García‐Marchena, N., Pavón, F. J., Serrano, A., de Fonseca, F. R., & Suárez, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00096 · Cited by 33
Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviour
McCabe, C., Shaw, D., Atack, J. R., Street, L. J., Wafford, K. A., Dawson, G. R., Reynolds, D. S., & Leslie, J. C. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.004 · Cited by 32
The role of mediodorsal thalamic nucleus in fear extinction
Lee, S., & Shin, H. (2016) · Journal of Analytical Science & Technology · doi:10.1186/s40543-016-0093-6 · Cited by 32
Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system
Wyrofsky, R. R., Reyes, B. A. S., Zhang, X.-Y., Bhatnagar, S., Kirby, L. G., & Bockstaele, E. J. V. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100176 · Cited by 31
Dvořáková, M., Kubik‐Zahorodna, A., Straiker, A. J., Sedláček, R., Hájková, A., Mackie, K., & Blahoš, J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15383 · Cited by 28
Translation of animal endocannabinoid models of PTSD mechanisms to humans: Where to next?
Ney, L. J., Crombie, K. M., Mayo, L. M., Felmingham, K. L., Bowser, T. A., & Matthews, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.040 · Cited by 30
Melis, M., Greco, B., & Tonini, R. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12501 · Cited by 31
Varodayan, F. P., Bajo, M., Soni, N., Luu, G., Madamba, S. G., Schweitzer, P., & Roberto, M. (2016) · Addiction Biology · doi:10.1111/adb.12369 · Cited by 33
Zarrindast, M., Kangarlu-Haghighi, K., Khalilzadeh, A., & Fazli‐Tabaei, S. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200605000-00004 · Cited by 31
Barbara, J., Auclair, N., Roisin, M. P., Otani, S., Valjent, E., Caboche, J., Soubrié, P., & Crépel, F. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02533.x · Cited by 31
Effects of drugs that potentiate GABA on extinction of positively-reinforced operant behaviour
Leslie, J. C., Shaw, D., McCabe, C., Reynolds, D. S., & Dawson, G. R. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.01.003 · Cited by 31
Sachser, R. M., Crestani, A. P., Quillfeldt, J. A., Souza, T. M. E., & Alvares, L. D. O. (2015) · Learning & Memory · doi:10.1101/lm.039891.115 · Cited by 36
Brzózka, M. M., Fischer, A., Falkai, P., & Havemann‐Reinecke, U. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.003 · Cited by 30
The Use of Medicinal Marijuana for Posttraumatic Stress Disorder
Yarnell, S. C. (2015) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.15r01786 · Cited by 30
Mazier, W., Saucisse, N., Simon, V., Cannich, A., Marsicano, G., Massa, F., & Cota, D. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.005 · Cited by 30
Self-citationCardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors
Silvani, A., Berteotti, C., Bastianini, S., Cohen, G., Martire, V. L., Mazza, R., Pagotto, U., Quarta, C., & Zoccoli, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100536 · Cited by 30
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats
de Carvalho, C. R., Pamplona, F. A., Cruz, J. S., & Takahashi, R. N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3331-2 · Cited by 31
Wise, L. E., Harloe, J. P., & Lichtman, A. H. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.06.001 · Cited by 31
Memory Formation in Reversal Learning of the Honeybee
Hadar, R., & Menzel, R. (2010) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2010.00186 · Cited by 33
Lester, K. J., Coleman, J. R. I., Roberts, S., Keers, R., Breen, G. D., Bögels, S. M., Creswell, C., Hudson, J. L., McKinnon, A., Nauta, M. H., et al. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32467 · Cited by 31
Kang-Park, M.-H., Wilson, W. A., Kuhn, C. M., Moore, S. D., & Swartzwelder, H. S. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00091.2007 · Cited by 30
Mohammadkhani, A., & Borgland, S. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24770 · Cited by 29
The neuroendocrine impact of acute stress on synaptic plasticity
dos-Santos, R. C., Sweeten, B. L. W., Stelly, C. E., & Tasker, J. G. (2023) · Endocrinology · doi:10.1210/endocr/bqad149 · Cited by 29
Shonesy, B. C., Winder, D. G., Patel, S., & Colbran, R. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.026 · Cited by 29
Targeting the Endocannabinoid System in Psychiatric Illness
Katzman, M. A., Furtado, M., & Anand, L. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000581 · Cited by 30
Río, I. B., Puente, N., Peñasco, S., Rico, I., Gutiérrez‐Rodrίguez, A., Elezgarai, I., Ramos, A., Reguero, L., Gerrikagoitia, I., Christie, B. R., et al. (2017) · Addiction Biology · doi:10.1111/adb.12585 · Cited by 30
Sugaya, Y., & Kano, M. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2834-8 · Cited by 28
Jennings, E. M., Okine, B. N., Olango, W. M., Roche, M., & Finn, D. P. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.008 · Cited by 29
Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures
Sugaya, Y., & Kano, M. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.781113 · Cited by 31
Niloy, N., Hediyal, T. A., Vichitra, C., Sharma, S., Chidambaram, S. B., Gorantla, V. R., & Mahalakshmi, A. M. (2023) · Biomolecules · doi:10.3390/biom13010162 · Cited by 28
Reguero, L., Puente, N., Elezgarai, I., Mendizabal‐Zubiaga, J., Canduela, M. J., Salazar, I. B., Ramos, A., Suárez, J., de Fonseca, F. R., Marsicano, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026167 · Cited by 29
Self-citationRoche, M., Johnston, P., Mhuircheartaigh, O. N., Olango, W. M., Mackie, K., & Finn, D. P. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2009.08.009 · Cited by 29
Pigeat, R., Chausson, P., Dreyfus, F. M., Leresche, N., & Lambert, R. C. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2748-14.2015 · Cited by 34
Brain CB1 receptor expression following lipopolysaccharide-induced inflammation
Hu, H., Ho, W., Mackie, K., Pittman, Q. J., & Sharkey, K. A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.067 · Cited by 29
Saito, V. M., Wotjak, C. T., & Moreira, F. A. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000500004 · Cited by 34
Self-citationZhang, M., Gao, Y., Btesh, J., Kagan, N., Kerns, E. H., Samad, T. A., & Chanda, P. K. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1701 · Cited by 28
Ghiasvand, M., Rezayof, A., Zarrindast, M., & Ahmadi, S. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.06.008 · Cited by 28
Olmo, I. G., Ferreira-Vieira, T. H., & Ribeiro, F. M. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.104372 · Cited by 28
Endocannabinoid signaling and memory dynamics: A synaptic perspective
Drumond, A., Madeira, N., & Fonseca, R. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.07.031 · Cited by 29
Murkar, A., Kent, P., Cayer, C., James, J., Durst, T., & Merali, Z. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00174 · Cited by 29
Crombie, K. M., Privratsky, A. A., Schomaker, C. M., Heilicher, M. O., Ross, M. C., Sartin‐Tarm, A., Sellnow, K. A., Binder, E. B., James, G. A., & Cisler, J. M. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102922 · Cited by 33
Expression of Functional Cannabinoid Type-1 (CB1) Receptor in Mitochondria of White Adipocytes
Zottola, A. C. P., Severi, I., Cannich, A., Ciofi, P., Cota, D., Marsicano, G., Giordano, A., & Bellocchio, L. (2022) · Cells · doi:10.3390/cells11162582 · Cited by 28
Self-citationSimone, J. J., Green, M. R., Hodges, T. E., & McCormick, C. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.012 · Cited by 30
Goonawardena, A. V., Sesay, J., Sexton, C. A., Riedel, G., & Hampson, R. E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.003 · Cited by 28
MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling
Chiarlone, A., Börner, C., Martín-Gómez, L., Jiménez-González, A., García-Concejo, A., García‐Bermejo, L., Lorente, M., Blázquez, C., García-Taboada, E., Haro, A., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.007 · Cited by 29
Endocannabinoid Signaling in Neural Plasticity
Alger, B. E. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_6 · Cited by 28
Fattore, L., Piva, A., Zanda, M. T., Fumagalli, G. F., & Chiamulera, C. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4793-4 · Cited by 26
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor
Porcu, A., Melis, M., Tureček, R., Ullrich, C., Mocci, I., Bettler, B., Gessa, G. L., & Castelli, M. P. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.024 · Cited by 28
Malcher‐Lopes, R. (2014) · Revista da Biologia · doi:10.7594/revbio.13.01.07 · Cited by 29
Developmental Alteration of Endocannabinoid Retrograde Signaling in the Hippocampus
Zhu, P., & Lovinger, D. M. (2009) · Journal of Neurophysiology · doi:10.1152/jn.00327.2009 · Cited by 27
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders
Janssen, F. J., & van der Stelt, M. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.06.076 · Cited by 27
Target-Dependent Control of Synaptic Inhibition by Endocannabinoids in the Thalamus
Sun, Y.-G., Wu, C., Lu, H., & Beierlein, M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0531-11.2011 · Cited by 27
Ballesteros‐Yáñez, I., Valverde, O., Ledent, C. A., Maldonado, R. J., & DeFelipe, J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.017 · Cited by 26
Warrier, A., & Wilson, M. (2007) · Visual Neuroscience · doi:10.1017/s0952523807230160 · Cited by 27
Korem, N., Lange, R., Hillard, C. J., & Akirav, I. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.015 · Cited by 27
Navarini, L., Bisogno, T., Mozetic, P., Piscitelli, F., Margiotta, D. P. E., Basta, F., Afeltra, A., & Maccarrone, M. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.04.010 · Cited by 27
Self-citationSegev, A., & Akirav, I. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.238 · Cited by 27
Achterberg, E. J. M., Trezza, V., & Vanderschuren, L. J. M. J. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000039 · Cited by 27
Genetic Manipulation of the Endocannabinoid System
Zimmer, A. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_5 · Cited by 26
Brose, S. A., Golovko, S. A., & Golovko, M. Y. (2016) · Lipids · doi:10.1007/s11745-016-4144-y · Cited by 26
Lee, S. H., Mak, A., & Verheijen, M. H. G. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1159756 · Cited by 26
Mitochondrial cannabinoid receptors gate corticosterone impact on novel object recognition
Skupio, U., Welte, J., Serrat, R., Eraso‐Pichot, A., Julio‐Kalajzić, F., Gisquet, D., Cannich, A., Delcasso, S., Matias, I., Fundazuri, U. B., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.001 · Cited by 29
Self-citationTamagnini, F., Barker, G., Warburton, E. C., Burattini, C., Aicardi, G., & Bashir, Z. I. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.254862 · Cited by 26
Ikeda, H., Ikegami, M., Kai, M., & Kamei, J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.04.012 · Cited by 26
Hu, S. S., Liu, Y.-W., & Yu, L. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3812-y · Cited by 26
Genn, R. F., Tucci, S. A., Parikh, S., & File, S. E. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1932-5 · Cited by 26
Propofol Sedation Is Reduced by Δ9-Tetrahydrocannabinol in Mice
Brand, P.-A., Paris, A., Bein, B., Meybohm, P., Scholz, J., Ohnesorge, H., & Tonner, P. H. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318173287a · Cited by 26
Zavitsanou, K., Dalton, V. S., Walker, A. K., Weickert, C. S., Sominsky, L., & Hodgson, D. M. (2013) · Synapse · doi:10.1002/syn.21640 · Cited by 26
Could a blood test for PTSD and depression be on the horizon?
Aspesi, D., & Pinna, G. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1544894 · Cited by 26
The endocannabinoid system and associative learning and memory in zebrafish
Ruhl, T., Moesbauer, K., Oellers, N., & von der Emde, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.046 · Cited by 26
Ten-Blanco, M., Flores, Á., Pereda-Pérez, I., Piscitelli, F., Izquierdo-Luengo, C., Cristino, L., Romero, J., Hillard, C. J., Maldonado, R. J., Marzo, V. D., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112925 · Cited by 29
Harm reduction-the cannabis paradox
Melamede, R. J. (2005) · Harm Reduction Journal · doi:10.1186/1477-7517-2-17 · Cited by 26
Delta-9-tetrahydrocannabinol enhances food reinforcement in a mouse operant conflict test
Barbano, M. F., Castañé, A., Martín‐García, E., & Maldonado, R. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1557-9 · Cited by 26
Brignell, C. M., & Curran, H. V. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0363-x · Cited by 26
Zusman, M. (2008) · Physical Therapy Reviews · doi:10.1179/174328808x251948 · Cited by 26
Sibaev, A., Massa, F., Yüce, B., Marsicano, G., Lehr, H. A., Lutz, B., Göke, B., Allescher, H. D., & Storr, M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0040-x · Cited by 26
Self-citationTrent, S., Abdullah, M. H., Parwana, K., Valdivieso, M. A., Hassan, Z., & Müller, C. P. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111310 · Cited by 33
The neuronal identity bias behind neocortical GABAergic plasticity
Allène, C., Lourenço, J., & Bacci, A. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.07.008 · Cited by 29
Grabiec, U., Koch, M., Kallendrusch, S., Kraft, R., Hill, K., Merkwitz, C., Ghadban, C., Lutz, B., Straiker, A. J., & Dehghani, F. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.023 · Cited by 25
Self-citationTalani, G., & Lovinger, D. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.08.006 · Cited by 25
Novel pharmacological treatment strategies for posttraumatic stress disorder
Thomas, E., & Stein, D. J. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1260001 · Cited by 24
Endocannabinoid Tone Regulates Human Sebocyte Biology
Zákány, N., Oláh, A., Markovics, A., Takács, E., Aranyász, A., Nicolussi, S., Piscitelli, F., Allarà, M., Pór, Á., Kovács, I., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.02.022 · Cited by 25
dos Santos, A. H., Fassini, A., Scopinho, A. A., Correa, F. M., Guimarães, F. S., Lisboa, S. F. D. S., & Resstel, L. B. M. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119827799 · Cited by 25
Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling
Hons, I. M., Storr, M., Mackie, K., Lutz, B., Pittman, Q. J., Mawe, G. M., & Sharkey, K. A. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01860.x · Cited by 25
Self-citationEndocannabinoid Receptors: CNS Localization of the CB1 Cannabinoid Receptor
Katona, I. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_3 · Cited by 25
Dual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptors
Diniz, C. R. A. F., Biojone, C., Joca, S. R. L., Rantamäki, T., Ċastrén, E., Guimarães, F. S., & Casarotto, P. C. (2019) · PeerJ · doi:10.7717/peerj.6493 · Cited by 25
Manchia, M., Comai, S., Pinna, M., Pinna, F., Fanos, V., Denovan‐Wright, E. M., & Carpiniello, B. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.004 · Cited by 26
Endocannabinoids as Therapeutic Targets
Prospero-Garcia, O. E., Ruiz‐Contreras, A. E., Ortega-Gómez, A., Herrera-Solís, A., & Méndez‐Díaz, M. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.09.005 · Cited by 26
BfCBR: A cannabinoid receptor ortholog in the cephalochordate Branchiostoma floridae (Amphioxus)
Elphick, M. R. (2007) · Gene · doi:10.1016/j.gene.2007.04.025 · Cited by 25
Spalletta, G., Bria, P., & Caltagirone, C. (2006) · Psychopathology · doi:10.1159/000096387 · Cited by 25
Highway to hell or magic smoke? The dose-dependence of Δ9-THC in place conditioning paradigmsPreprint
Kubilius, R. A., Kaplick, P. M., & Wotjak, C. T. (2018) · Learning & Memory · doi:10.1101/lm.046870.117 · Cited by 25
Self-citation
Metadata
- Authors
- Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., Di Marzo, V., & Lutz, B.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- LMU Klinikum (DE)
- Istituto di Chimica Biomolecolare (IT)
- Helmholtz Munich (DE)
- Corresponding author
- Lutz, Beat
- Venue
- Nature
- Published
- 2002-08
- Volume
- 418
- Issue
- 6897
- Pages
- 530-534
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982291289
- Cited by
- 1,728
- References
- 30
- Citations by year
- 2026: 22 · 2025: 39 · 2024: 41 · 2023: 48 · 2022: 60 · 2021: 61 · 2020: 60 · 2019: 70 · 2018: 64 · 2017: 77 · 2016: 75 · 2015: 87 · 2014: 90 · 2013: 87 · 2012: 85
- FWCI
- 42.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- endocannabinoid system, CB1 receptor, CB1 knockout mice, fear extinction, auditory fear conditioning, basolateral amygdala, long-term depression, GABAergic inhibition, SR141716A, memory consolidation, inhibitory neural networks
- MeSH terms
- Rimonabant, Acoustic Stimulation, Amygdala, Animals, Cannabinoids, Conditioning, Classical, Electrophysiology, Extinction, Psychological, Fear, gamma-Aminobutyric Acid, Male, Memory, Mice, Inbred C57BL, Neuronal Plasticity, Neurons, Piperidines, Pyrazoles, Receptors, Drug, Synapses, Gene Deletion, Mice, Knockout, Receptors, Cannabinoid, Mice, Cannabinoid Receptor Modulators, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
